Related references
Note: Only part of the references are listed.Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer
Clelia Coutzac et al.
NATURE COMMUNICATIONS (2020)
Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer
Xue Dong et al.
SCIENCE ADVANCES (2020)
An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure
Di-Wei Zheng et al.
NATURE BIOMEDICAL ENGINEERING (2020)
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Lukas F. Mager et al.
SCIENCE (2020)
Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
Elisabeth Perez-Ruiz et al.
NATURE (2019)
Cancer nanomedicine for combination cancer immunotherapy
Jutaek Nam et al.
NATURE REVIEWS MATERIALS (2019)
Bacterium-Mimicking Vector with Enhanced Adjuvanticity for Cancer Immunotherapy and Minimized Toxicity
Binbin Zheng et al.
ADVANCED FUNCTIONAL MATERIALS (2019)
Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy
Di-Wei Zheng et al.
NATURE BIOMEDICAL ENGINEERING (2019)
Development of an In Situ Cancer Vaccine via Combinational Radiation and Bacterial-Membrane-Coated Nanoparticles
Ravi B. Patel et al.
ADVANCED MATERIALS (2019)
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
Erick Riquelme et al.
CELL (2019)
Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity
Xiaohang Long et al.
NATURE MICROBIOLOGY (2019)
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
Ezra E. W. Cohen et al.
LANCET (2019)
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
Qian Chen et al.
NATURE NANOTECHNOLOGY (2019)
Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4
Zhiyong Wang et al.
NATURE COMMUNICATIONS (2019)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Superparamagnetic nickel colloidal nanocrystal clusters with antibacterial activity and bacteria binding ability
Bo Peng et al.
NATURE NANOTECHNOLOGY (2018)
Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier
Eric C. Martens et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Optically-controlled bacterial metabolite for cancer therapy
Di-Wei Zheng et al.
NATURE COMMUNICATIONS (2018)
Sex dependent effects of silver nanoparticles on the zebrafish gut microbiota
Yanbo Ma et al.
ENVIRONMENTAL SCIENCE-NANO (2018)
TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
Christopher B. Rodell et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses
Yu Chao et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Human Papilloma Virus Specific Immunogenicity and Dysfunction of CD8+ T Cells in Head and Neck Cancer
Krishna et al.
CANCER RESEARCH (2018)
Tumour-targeting bacteria engineered to fight cancer
Shibin Zhou et al.
NATURE REVIEWS CANCER (2018)
Platelet-Facilitated Photothermal Therapy of Head and Neck Squamous Cell Carcinoma
Lang Rao et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice
Ho Tsoi et al.
GASTROENTEROLOGY (2017)
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
Yuanzeng Min et al.
NATURE NANOTECHNOLOGY (2017)
Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin
Jin Hai Zheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Variations in oral microbiota associated with oral cancer
Hongsen Zhao et al.
SCIENTIFIC REPORTS (2017)
Photo-Inspired Antibacterial Activity and Wound Healing Acceleration by Hydrogel Embedded with Ag/Ag@AgCl/ZnO Nanostructures
Congyang Mao et al.
ACS NANO (2017)
Predictive biomarkers for checkpoint inhibitor-based immunotherapy
Geoffrey T. Gibney et al.
LANCET ONCOLOGY (2016)
Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model
Joao Conde et al.
NATURE MATERIALS (2016)
Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations
Axel Hoos
NATURE REVIEWS DRUG DISCOVERY (2016)
LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma
Wei-Wei Deng et al.
ONCOIMMUNOLOGY (2016)
The head and neck cancer immune landscape and its immunotherapeutic implications
Rajarsi Mandal et al.
JCI INSIGHT (2016)
Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance
Joao Conde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer
Cecile Badoual et al.
CANCER RESEARCH (2013)
The molecular biology of head and neck cancer
C. Rene Leemans et al.
NATURE REVIEWS CANCER (2011)
Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model
Katerina Strati et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Bacterial silver resistance: molecular biology and uses and misuses of silver compounds
S Silver
FEMS MICROBIOLOGY REVIEWS (2003)
Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway
H Hemmi et al.
NATURE IMMUNOLOGY (2002)
Share Paper
